Humana Inc. (NYSE:HUM) Shares Sold by California State Teachers Retirement System

California State Teachers Retirement System decreased its holdings in shares of Humana Inc. (NYSE:HUM) by 0.4% during the first quarter, HoldingsChannel.com reports. The institutional investor owned 196,844 shares of the insurance provider’s stock after selling 763 shares during the quarter. California State Teachers Retirement System’s holdings in Humana were worth $68,250,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of the company. Raymond James Financial Services Advisors Inc. grew its stake in shares of Humana by 13.8% in the 4th quarter. Raymond James Financial Services Advisors Inc. now owns 19,676 shares of the insurance provider’s stock valued at $9,008,000 after purchasing an additional 2,390 shares during the period. Assenagon Asset Management S.A. boosted its stake in shares of Humana by 2.6% during the 4th quarter. Assenagon Asset Management S.A. now owns 4,250 shares of the insurance provider’s stock worth $1,946,000 after buying an additional 109 shares during the last quarter. Gradient Investments LLC lifted its stake in Humana by 200.0% in the 4th quarter. Gradient Investments LLC now owns 60 shares of the insurance provider’s stock valued at $27,000 after purchasing an additional 40 shares during the last quarter. AdvisorNet Financial Inc lifted its position in Humana by 357.7% during the fourth quarter. AdvisorNet Financial Inc now owns 920 shares of the insurance provider’s stock worth $421,000 after acquiring an additional 719 shares during the last quarter. Finally, Claro Advisors LLC increased its holdings in shares of Humana by 12.1% during the fourth quarter. Claro Advisors LLC now owns 554 shares of the insurance provider’s stock worth $254,000 after purchasing an additional 60 shares during the period. Institutional investors and hedge funds own 92.38% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on HUM shares. UBS Group cut their price target on shares of Humana from $334.00 to $326.00 and set a “neutral” rating on the stock in a report on Thursday, April 25th. Wells Fargo & Company dropped their price target on shares of Humana from $413.00 to $350.00 and set an “overweight” rating on the stock in a research note on Monday, April 8th. Cantor Fitzgerald reissued a “neutral” rating and issued a $360.00 price target on shares of Humana in a report on Tuesday, July 23rd. Jefferies Financial Group dropped their target price on shares of Humana from $411.00 to $381.00 and set a “buy” rating for the company in a research report on Monday, April 22nd. Finally, Morgan Stanley started coverage on shares of Humana in a research note on Monday, June 24th. They set an “equal weight” rating and a $374.00 price objective on the stock. Fourteen equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $404.10.

Humana Price Performance

Shares of Humana stock traded down $5.79 during midday trading on Thursday, hitting $355.82. 45,932 shares of the company were exchanged, compared to its average volume of 1,740,314. The firm has a 50 day simple moving average of $367.48 and a 200-day simple moving average of $347.60. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.67 and a quick ratio of 1.67. Humana Inc. has a 52 week low of $298.61 and a 52 week high of $530.54. The firm has a market cap of $42.88 billion, a P/E ratio of 22.60, a PEG ratio of 2.34 and a beta of 0.51.

Humana (NYSE:HUM) last posted its earnings results on Wednesday, July 31st. The insurance provider reported $6.96 earnings per share for the quarter, topping the consensus estimate of $5.89 by $1.07. The firm had revenue of $29.54 billion for the quarter, compared to analyst estimates of $28.52 billion. Humana had a return on equity of 17.76% and a net margin of 1.82%. The company’s revenue for the quarter was up 10.4% on a year-over-year basis. During the same period in the previous year, the company posted $8.94 earnings per share. Research analysts forecast that Humana Inc. will post 16.27 earnings per share for the current year.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.